Michelle L. Basil, EVP and General Counsel at HAEMONETICS CORP (HAE), sold 4,950 shares at $95.08 ($471K) on 2024-05-20, disclosed to the SEC on 2024-05-21.
Scheduled sale ($471k) by EVP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.00 | 1,073 | $102K | 21.6% |
| 2 | $95.73 | 669 | $64K | 13.6% |
| 3 | $95.08 | 1,604 | $153K | 32.4% |
| 4 | $95.08 | 1,604 | $153K | 32.4% |
| Total | $95.15 avg | 4,950 | $471K | 100% |
| Filing → |
| HAE | SELL | 2022-10-26 | $14K | — | Filing → |
| HAE | SELL | 2022-09-21 | $1.8M | — | Filing → |
| HAE | SELL | 2022-09-19 | $5.3M | — | Filing → |